The Prognostic Value of Liquid Biopsies for Benefit of Salvage Radiotherapy in Relapsed Oligometastatic Prostate Cancer

SIMPLE SUMMARY: Around 30% of patients with oligometastatic prostate cancer relapse will benefit from local PET/CT-guided ablative radiotherapy (RT) with improved progression-free and ADT (Androgene Deprivation Therapy)-free survivals. Therefore, there is an urgent need for predictive testing for th...

Descripción completa

Detalles Bibliográficos
Autores principales: Bogdanova, Natalia V., Radmanesh, Hoda, Ramachandran, Dhanya, Knoechelmann, Anne Caroline, Christiansen, Hans, Derlin, Thorsten, von Klot, Christoph Alexander Joachim, Merten, Roland, Henkenberens, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454496/
https://www.ncbi.nlm.nih.gov/pubmed/36077632
http://dx.doi.org/10.3390/cancers14174095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454496/
https://www.ncbi.nlm.nih.gov/pubmed/36077632
http://dx.doi.org/10.3390/cancers14174095

Ejemplares similares